메뉴 건너뛰기




Volumn 19, Issue 21, 2012, Pages 3457-3474

Recent advances in the development of selective CB2 agonists as promising anti-inflammatory agents

Author keywords

Aminoalkylindoles; Anti inflammatory agents; Cannabinoids; Central nervous system inflammation; Chronic inflammatory diseases; Crohn's disease; IBD; Inflammation; Ischemia reperfusion injury; Morpholines; Quinolones; Tricyclic pyrazoles; Ulcerative colitis

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2 ARACHIDONOYLGLYCEROL; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; ANTIINFLAMMATORY AGENT; CANNABIDIOL; CANNABINOID 2 RECEPTOR; CANNABINOID 2 RECEPTOR AGONIST; CANNABINOL; DEXANABINOL; DRONABINOL; GW 842166; KN 387271; N ARACHIDONOYLDOPAMINE; N DOCOSATETRAENOYLETHANOLAMINE; N OLEOYLDOPAMINE; NABIXIMOLS; NOLADIN ETHER; O 1602; OLEAMIDE; PALMITOYLETHANOLAMINE; RILUZOLE; S 777469; TEDALINAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRODHAMINE;

EID: 84863773667     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712801323207     Document Type: Article
Times cited : (31)

References (221)
  • 1
    • 33947489961 scopus 로고
    • Isolation, structure and partial synthesis of an active constituent of hashish
    • Yechiel, G.; Mechoulam, R. Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc., 1964, 86(8), 1646-1647
    • (1964) J. Am. Chem. Soc. , vol.86 , Issue.8 , pp. 1646-1647
    • Yechiel, G.1    Mechoulam, R.2
  • 2
    • 0344823856 scopus 로고    scopus 로고
    • Pain and cannabinoids: Science and evidence
    • Farquhar-Smith, W. P. Pain and cannabinoids: science and evidence. Pain Rev., 2002, 9, 41-67
    • (2002) Pain Rev. , vol.9 , pp. 41-67
    • Farquhar-Smith, W.P.1
  • 3
    • 18844400058 scopus 로고    scopus 로고
    • Cannabinoid-based drugs as anti-inflammatory therapy
    • Klein, T.W. Cannabinoid-based drugs as anti-inflammatory therapy. Nat. Rev. Immunol., 2005, 5, 400-411
    • (2005) Nat. Rev. Immunol. , vol.5 , pp. 400-411
    • Klein, T.W.1
  • 4
    • 1842611884 scopus 로고    scopus 로고
    • Cannabinoids and neuroinflammation
    • Walter, L.; Stella, N. Cannabinoids and neuroinflammation. B r. J. Pharmacol., 2004, 141, 75-785
    • (2004) B R. J. Pharmacol. , vol.141 , pp. 75-785
    • Walter, L.1    Stella, N.2
  • 5
    • 21344455919 scopus 로고    scopus 로고
    • Cannabinoids as potential anti-epileptic drugs
    • Smith, P.F. Cannabinoids as potential anti-epileptic drugs. Curr. Opin. Invest. Drugs, 2005, 6, 680-685
    • (2005) Curr. Opin. Invest. Drugs , vol.6 , pp. 680-685
    • Smith, P.F.1
  • 6
    • 33144480327 scopus 로고    scopus 로고
    • Cannabinoid receptors as therapeutic targets
    • Mackie, K. Cannabinoid receptors as therapeutic targets. Annu. Rev. Pharmacol. Toxicol., 2006, 46, 101-122
    • (2006) Annu. Rev. Pharmacol. Toxicol. , vol.46 , pp. 101-122
    • MacKie, K.1
  • 7
    • 33645796477 scopus 로고    scopus 로고
    • Cannabinoids
    • Pertwee Ed. Springer-Verlag: Heidelberg, Germany
    • Howlett, A.C. In: Cannabinoids. Handbook of Experimental Pharmacology; Pertwee, Ed., Springer-Verlag: Heidelberg, Germany, 2005; Vol. 168, pp. 53-79
    • (2005) Handbook of Experimental Pharmacology , vol.168 , pp. 53-79
    • Howlett, A.C.1
  • 12
    • 33645794041 scopus 로고    scopus 로고
    • Cannabinoids
    • Pertwee, Ed.; Springer-Verlag: Heidelberg, Germany
    • Di Marzo, V. In: Cannabinoids. Handbook of Experimental Pharmacology; Pertwee, Ed.; Springer-Verlag: Heidelberg, Germany, 2005; Vol. 168, pp. 147-185
    • (2005) Handbook of Experimental Pharmacology , vol.168 , pp. 147-185
    • Di Marzo, V.1
  • 13
    • 33644804271 scopus 로고    scopus 로고
    • The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids
    • Pertwee, R.G. The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J., 2005, 7, E625-E654
    • (2005) AAPS J. , vol.7
    • Pertwee, R.G.1
  • 14
    • 4644372326 scopus 로고    scopus 로고
    • The endogenous cannabinoid system and its role in nociceptive behavior
    • Cravatt, B.F.; Lichtman, A.H. The endogenous cannabinoid system and its role in nociceptive behavior. J. Neurobiol, 2004, 61(1), 149-160
    • (2004) J. Neurobiol , vol.61 , Issue.1 , pp. 149-160
    • Cravatt, B.F.1    Lichtman, A.H.2
  • 15
    • 0344441315 scopus 로고    scopus 로고
    • Cellular accumulation of anandamide: Consensus and controversy
    • Hillard, C.J.; Jarrahian, A. Cellular accumulation of anandamide: consensus and controversy. Br. J. Pharmacol, 2003, 140(5), 802-808
    • (2003) Br. J. Pharmacol , vol.140 , Issue.5 , pp. 802-808
    • Hillard, C.J.1    Jarrahian, A.2
  • 16
    • 33645795765 scopus 로고    scopus 로고
    • Cannabinoids
    • Pertwee, Ed.; Springer-Verlag: Heidelberg, Germany
    • Vaughan, C.W.; Christie, M.J. In: Cannabinoids. Handbook of Experimental Pharmacology; Pertwee, Ed.; Springer-Verlag: Heidelberg, Germany, 2005; Vol. 168, pp. 367-383
    • (2005) Handbook of Experimental Pharmacology , vol.168 , pp. 367-383
    • Vaughan, C.W.1    Christie, M.J.2
  • 17
    • 84859047666 scopus 로고    scopus 로고
    • Cannabinoids
    • Pertwee, Ed.; Springer-Verlag: Heidelberg, Germany
    • Cabral, G.A.; Staab, A. In: Cannabinoids. Handbook of Experimental Pharmacology; Pertwee, Ed.; Springer-Verlag: Heidelberg, Germany, 2005; Vol. 168, pp. 385-423
    • (2005) Handbook of Experimental Pharmacology , vol.168 , pp. 385-423
    • Cabral, G.A.1    Staab, A.2
  • 18
    • 0025325535 scopus 로고
    • Structure of a cannabinoid receptor and functional expression of the cloned cDNA
    • Munro, L.A.; Lolait, S.J.; Brownstein, M.J.; Young, A.C.; Bonner, T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 1990, 346, 561-564
    • (1990) Nature , vol.346 , pp. 561-564
    • Munro, L.A.1    Lolait, S.J.2    Brownstein, M.J.3    Young, A.C.4    Bonner, T.I.5
  • 19
    • 0033545866 scopus 로고    scopus 로고
    • Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
    • Zimmer, A.; Zimmer, A.M.; Hohmann, A.G.; Herkenham, M.; Bonner, T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. U S A., 1999, 96(10), 5780-5785
    • (1999) Proc. Natl. Acad. Sci. U S A. , vol.96 , Issue.10 , pp. 5780-5785
    • Zimmer, A.1    Zimmer, A.M.2    Hohmann, A.G.3    Herkenham, M.4    Bonner, T.I.5
  • 21
    • 53549119424 scopus 로고    scopus 로고
    • An endocannabinoid hypothesis of drug reward and drug addiction
    • Onaivi, E.S. An endocannabinoid hypothesis of drug reward and drug addiction. Ann. N Y. Acad. Sci., 2008, 1139, 412-421
    • (2008) Ann. N Y. Acad. Sci. , vol.1139 , pp. 412-421
    • Onaivi, E.S.1
  • 22
    • 33748703859 scopus 로고    scopus 로고
    • The endocannabinoid system as an emerging target of pharmacotherapy
    • Pacher, P.; Bátkai, S.; Kunos, G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev., 2006, 58(3), 389-462
    • (2006) Pharmacol. Rev. , vol.58 , Issue.3 , pp. 389-462
    • Pacher, P.1    Bátkai, S.2    Kunos, G.3
  • 23
    • 42349116262 scopus 로고    scopus 로고
    • Cannabinoid receptors: Where they are and what they do
    • Mackie, K. Cannabinoid receptors: where they are and what they do. J. Neuroendocrinol, 2008, 20, 10-14
    • (2008) J. Neuroendocrinol , vol.20 , pp. 10-14
    • MacKie, K.1
  • 24
    • 58149138840 scopus 로고    scopus 로고
    • Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain?
    • Kunos, G.; Osei-Hyiaman, D.; Bátkai, S.; Sharkey, K.A.; Makriyannis, A. Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain? Trends Pharmacol. Sci., 2009, 30(1), 1-7
    • (2009) Trends Pharmacol. Sci. , vol.30 , Issue.1 , pp. 1-7
    • Kunos, G.1    Osei-Hyiaman, D.2    Bátkai, S.3    Sharkey, K.A.4    Makriyannis, A.5
  • 25
    • 0027515373 scopus 로고
    • Molecular characterization of a peripheral receptor for cannabinoids
    • Munro, S.; Thomas, K.L.; Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature, 1993, 365, 61-65
    • (1993) Nature , vol.365 , pp. 61-65
    • Munro, S.1    Thomas, K.L.2    Abu-Shaar, M.3
  • 27
    • 33244493807 scopus 로고    scopus 로고
    • Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
    • Ashton, J.C.; Friberg, D.; Darlington, C.L.; Smith, PF. Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study. Neurosci. Lett, 2006, 396(2), 113-116
    • (2006) Neurosci. Lett , vol.396 , Issue.2 , pp. 113-116
    • Ashton, J.C.1    Friberg, D.2    Darlington, C.L.3    Smith, P.F.4
  • 29
    • 63049105150 scopus 로고    scopus 로고
    • Emerging role of the cannabinoid receptor CB2 in immune regulation: Therapeutic prospects for neuroinflammation
    • Cabral, G.A.; Griffin-Thomas, L. Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert. Rev. Mol Med., 2009, 11, e3
    • (2009) Expert. Rev. Mol Med. , vol.11
    • Cabral, G.A.1    Griffin-Thomas, L.2
  • 30
    • 38349119715 scopus 로고    scopus 로고
    • Cannabinoid CB2 receptors: A therapeutic target for the treatment of inflammatory and neuropathic pain
    • Guindon, J.; Hohmann, A.G. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br. J. Pharmacol, 2008, 153, 319-334
    • (2008) Br. J. Pharmacol , vol.153 , pp. 319-334
    • Guindon, J.1    Hohmann, A.G.2
  • 34
    • 77957273334 scopus 로고    scopus 로고
    • Understanding Functional Residues of the Cannabinoid CB1 Receptor for Drug Discovery
    • Shim, J.-Y Understanding Functional Residues of the Cannabinoid CB1 Receptor for Drug Discovery. Curr. Top. Med. Chem., 2010, 10(8), 779-798
    • (2010) Curr. Top. Med. Chem. , vol.10 , Issue.8 , pp. 779-798
    • Shim, J.-Y.1
  • 36
    • 12844283365 scopus 로고    scopus 로고
    • The conformation of the cytoplasmic helix 8 of the CB1 cannabinoid receptor using NMR and circular dichroism
    • Choi, G.; Guo, J.; Makriyannis, A. The conformation of the cytoplasmic helix 8 of the CB1 cannabinoid receptor using NMR and circular dichroism. Biochim. Biophys. Acta., 2005, 1668(1), 1-9
    • (2005) Biochim. Biophys. Acta. , vol.1668 , Issue.1 , pp. 1-9
    • Choi, G.1    Guo, J.2    Makriyannis, A.3
  • 37
    • 65249115932 scopus 로고    scopus 로고
    • Solid-state NMR and molecular dynamics characterization of cannabinoid receptor-1 (CB1) helix 7 conformational plasticity in model membranes
    • Tiburu, E.K.; Bowman, A.L.; Struppe, J.O.; Janero, D.R.; Avraham, H.K.; Makriyannis, A. Solid-state NMR and molecular dynamics characterization of cannabinoid receptor-1 (CB1) helix 7 conformational plasticity in model membranes. Biochim. Biophys. Acta., 2009, 1788(5), 1159-1167
    • (2009) Biochim. Biophys. Acta. , vol.1788 , Issue.5 , pp. 1159-1167
    • Tiburu, E.K.1    Bowman, A.L.2    Struppe, J.O.3    Janero, D.R.4    Avraham, H.K.5    Makriyannis, A.6
  • 38
    • 13544267409 scopus 로고    scopus 로고
    • NMR structural comparison of the cytoplasmic juxtamembrane domains of G-protein-coupled CB1 and CB2 receptors in membrane mimetic dodecylphosphocholine micelles
    • Xie, X.Q.; Chen, J.Z. NMR structural comparison of the cytoplasmic juxtamembrane domains of G-protein-coupled CB1 and CB2 receptors in membrane mimetic dodecylphosphocholine micelles. J. Biol. Chem., 2005, 280(5), 3605-3612
    • (2005) J. Biol. Chem. , vol.280 , Issue.5 , pp. 3605-3612
    • Xie, X.Q.1    Chen, J.Z.2
  • 39
    • 33646413423 scopus 로고    scopus 로고
    • NMR characterization of recombinant transmembrane protein CB2 fragment CB2(180-233)
    • Zhao, J.; Zheng, H.; Xie, X.Q. NMR characterization of recombinant transmembrane protein CB2 fragment CB2(180-233). Protein Pept. Lett., 2006, 13(4), 335-342
    • (2006) Protein Pept. Lett. , vol.13 , Issue.4 , pp. 335-342
    • Zhao, J.1    Zheng, H.2    Xie, X.Q.3
  • 40
    • 42749091750 scopus 로고    scopus 로고
    • Biosynthesis, purification, and characterization of a cannabinoid receptor 2 fragment (CB2(271-326))
    • Zhang, Y.; Xie, X.Q. Biosynthesis, purification, and characterization of a cannabinoid receptor 2 fragment (CB2(271-326)). Protein Expr. Purif., 2008, 59(2), 249-257
    • (2008) Protein Expr. Purif. , vol.59 , Issue.2 , pp. 249-257
    • Zhang, Y.1    Xie, X.Q.2
  • 41
    • 0036729440 scopus 로고    scopus 로고
    • The cytoplasmic helix of cannabinoid receptor CB2, a conformational study by circular dichroism and (1)H NMR spectroscopy in aqueous and membrane-like environments
    • Choi, G.; Landin, J.; Xie, X.Q. The cytoplasmic helix of cannabinoid receptor CB2, a conformational study by circular dichroism and (1)H NMR spectroscopy in aqueous and membrane-like environments. J. Pept. Res., 2002, 60(3), 169-177
    • (2002) J. Pept. Res. , vol.60 , Issue.3 , pp. 169-177
    • Choi, G.1    Landin, J.2    Xie, X.Q.3
  • 42
    • 33748363914 scopus 로고    scopus 로고
    • A transmembrane helix-bundle from G-protein coupled receptor CB2: Biosynthesis, purification, and NMR characterization
    • Zheng, H.; Zhao, J.; Sheng, W.; Xie, X.Q. A transmembrane helix-bundle from G-protein coupled receptor CB2: biosynthesis, purification, and NMR characterization. Biopolymers., 2006, 83(1), 46-61
    • (2006) Biopolymers. , vol.83 , Issue.1 , pp. 46-61
    • Zheng, H.1    Zhao, J.2    Sheng, W.3    Xie, X.Q.4
  • 46
    • 0033769188 scopus 로고    scopus 로고
    • Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: Evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain
    • Di Marzo, V.; Breivogel, C.S.; Tao, Q.; Bridgen, D.T.; Razdan, R.K.; Zimmer, A.M.; Zimmer, A.; Martin, B.R. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J. Neurochem., 2000, 75, 2434-2444
    • (2000) J. Neurochem. , vol.75 , pp. 2434-2444
    • Di Marzo, V.1    Breivogel, C.S.2    Tao, Q.3    Bridgen, D.T.4    Razdan, R.K.5    Zimmer, A.M.6    Zimmer, A.7    Martin, B.R.8
  • 47
    • 0035801320 scopus 로고    scopus 로고
    • Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus
    • Hajos, N.; Ledent, C.; Freund, T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience, 2001, 106, 1-4
    • (2001) Neuroscience , vol.106 , pp. 1-4
    • Hajos, N.1    Ledent, C.2    Freund, T.F.3
  • 50
    • 0038561226 scopus 로고    scopus 로고
    • Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery
    • Ho, W.S.; Hiley, C.R. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. B r. J. Pharmacol., 2003, 138, 1320-332
    • (2003) B R. J. Pharmacol. , vol.138 , pp. 1320-1332
    • Ho, W.S.1    Hiley, C.R.2
  • 51
    • 0042934012 scopus 로고    scopus 로고
    • Evidence for cannabinoid receptor-dependent and-independent mechanisms of action in leukocytes
    • Kaplan, B.L.; Rockwell, C.E.; Kaminski, N.E. Evidence for cannabinoid receptor-dependent and-independent mechanisms of action in leukocytes. J. Pharmacol. Exp. Ther., 2003, 306, 1077-1085
    • (2003) J. Pharmacol. Exp. Ther. , vol.306 , pp. 1077-1085
    • Kaplan, B.L.1    Rockwell, C.E.2    Kaminski, N.E.3
  • 53
    • 2542555018 scopus 로고    scopus 로고
    • The complexities of the cardiovascular actions of cannabinoids
    • Randall, M.D.; Kendall, D.A.; O'Sullivan, S. The complexities of the cardiovascular actions of cannabinoids. Br. J. Pharmacol., 2004, 142, 20-26
    • (2004) Br. J. Pharmacol. , vol.142 , pp. 20-26
    • Randall, M.D.1    Kendall, D.A.2    O'Sullivan, S.3
  • 54
    • 0032924113 scopus 로고    scopus 로고
    • Mesenteric vasodilation mediated by endothelial anandamide receptors
    • Wagner, J.A.; Varga, K.; Jarai, Z.; Kunos, G. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension, 1999, 33, 429-434
    • (1999) Hypertension , vol.33 , pp. 429-434
    • Wagner, J.A.1    Varga, K.2    Jarai, Z.3    Kunos, G.4
  • 60
    • 34249933789 scopus 로고    scopus 로고
    • Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion
    • Bifulco, M.; Laezza, C.; Gazzerro, P; Pentimalli, F. Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion. Oncol. Rep., 2007, 17, 813-816
    • (2007) Oncol. Rep. , vol.17 , pp. 813-816
    • Bifulco, M.1    Laezza, C.2    Gazzerro, P.3    Pentimalli, F.4
  • 61
    • 33749165439 scopus 로고    scopus 로고
    • Endocannabinoid overactivity and intestinal inflammation
    • Di Marzo, V.; Izzo, A.A. Endocannabinoid overactivity and intestinal inflammation. Gut, 2006, 55, 1373-1376
    • (2006) Gut , vol.55 , pp. 1373-1376
    • Di Marzo, V.1    Izzo, A.A.2
  • 63
    • 0033661798 scopus 로고    scopus 로고
    • Cannabinoid receptors and the regulation of immune response
    • Berdyshev, E.V. Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids, 2000, 108, 169-190
    • (2000) Chem. Phys. Lipids , vol.108 , pp. 169-190
    • Berdyshev, E.V.1
  • 64
    • 23244457833 scopus 로고    scopus 로고
    • Differential expression of cannabinoid receptors in the human colon: Cannabinoids promote epithelial wound healing
    • Wright, K.; Rooney, N.; Feeney, M.; Tate, J.; Robertson, D.; Welham, M.; Ward, S. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology, 2005, 129, 437-453
    • (2005) Gastroenterology , vol.129 , pp. 437-453
    • Wright, K.1    Rooney, N.2    Feeney, M.3    Tate, J.4    Robertson, D.5    Welham, M.6    Ward, S.7
  • 67
    • 0038678773 scopus 로고    scopus 로고
    • Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor
    • Klegeris, A.; Bissonnette, C.J.; McGeer, P.L. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. B r. J. Pharmacol., 2003, 139(4), 775-786
    • (2003) B R. J. Pharmacol. , vol.139 , Issue.4 , pp. 775-786
    • Klegeris, A.1    Bissonnette, C.J.2    McGeer, P.L.3
  • 68
    • 0037089221 scopus 로고    scopus 로고
    • Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol
    • Jordà, M.A.; Verbakel, S.E.; Valk, P.J.; Vankan-Berkhoudt, Y.V.; Maccarrone, M.; Finazzi-Agrò, A.; Löwenberg, B.; Delwel, R. Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood, 2002, 99(8), 2786-2793
    • (2002) Blood , vol.99 , Issue.8 , pp. 2786-2793
    • Jordà, M.A.1    Verbakel, S.E.2    Valk, P.J.3    Vankan-Berkhoudt, Y.V.4    MacCarrone, M.5    Finazzi-Agrò, A.6    Löwenberg, B.7    Delwel, R.8
  • 69
    • 33847420442 scopus 로고    scopus 로고
    • Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis
    • Benito, C.; Romero, J.P.; Tolon, R.M.; Clemente, D.; Docagne, F.; Hillard, C.J.; Guaza, C.; Romero, J. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J. Neurosci., 2007, 27(9), 2396-2402
    • (2007) J. Neurosci. , vol.27 , Issue.9 , pp. 2396-2402
    • Benito, C.1    Romero, J.P.2    Tolon, R.M.3    Clemente, D.4    Docagne, F.5    Hillard, C.J.6    Guaza, C.7    Romero, J.8
  • 70
    • 64249138218 scopus 로고    scopus 로고
    • The therapeutic potential of novel cannabinoid receptors
    • Kreitzer, F.R.; Stella, N. The therapeutic potential of novel cannabinoid receptors. Pharmacol. Ther., 2009, 122(2), 83-96
    • (2009) Pharmacol. Ther. , vol.122 , Issue.2 , pp. 83-96
    • Kreitzer, F.R.1    Stella, N.2
  • 71
    • 17444370570 scopus 로고    scopus 로고
    • Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
    • Lastres-Becker, I.; Molina-Holgado, F.; Ramos, J.A.; Mechoulam, R.; Fernandez-Ruiz, J. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. Neurobiol. Dis., 2005, 19(1-2), 96-107
    • (2005) Neurobiol. Dis. , vol.19 , Issue.1-2 , pp. 96-107
    • Lastres-Becker, I.1    Molina-Holgado, F.2    Ramos, J.A.3    Mechoulam, R.4    Fernandez-Ruiz, J.5
  • 72
    • 66449132820 scopus 로고    scopus 로고
    • WIN55, 212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease
    • Price, D.A.; Martinez, A.A.; Seillier, A.; Koek, W.; Acosta, Y.; Fernandez, E.; Strong, R.; Lutz, B.; Marsicano, G.; Roberts, J.L.; Giuffrida, A. WIN55, 212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease. Eur. J. Neurosci., 2009, 29(11), 2177-2186
    • (2009) Eur. J. Neurosci. , vol.29 , Issue.11 , pp. 2177-2186
    • Price, D.A.1    Martinez, A.A.2    Seillier, A.3    Koek, W.4    Acosta, Y.5    Fernandez, E.6    Strong, R.7    Lutz, B.8    Marsicano, G.9    Roberts, J.L.10    Giuffrida, A.11
  • 73
    • 33947278309 scopus 로고    scopus 로고
    • The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
    • Shoemaker, J.L.; Seely, K.A.; Reed, R.L.; Crow, J.P.; Prather, P.L. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J. Neurochem., 2007, 101(1), 87-98
    • (2007) J. Neurochem. , vol.101 , Issue.1 , pp. 87-98
    • Shoemaker, J.L.1    Seely, K.A.2    Reed, R.L.3    Crow, J.P.4    Prather, P.L.5
  • 75
    • 0348010292 scopus 로고    scopus 로고
    • Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains
    • Benito, C.; Núñez, E.; Tolón, R.M.; Carrier, E.J.; Rábano, A.; Hillard, C.J.; Romero, J. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J. Neurosci., 2003, 23(35), 11136-11141
    • (2003) J. Neurosci. , vol.23 , Issue.35 , pp. 11136-11141
    • Benito, C.1    Núñez, E.2    Tolón, R.M.3    Carrier, E.J.4    Rábano, A.5    Hillard, C.J.6    Romero, J.7
  • 79
    • 0037440415 scopus 로고    scopus 로고
    • Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide
    • Facchinetti, F.; Del Giudice, E.; Furegato, S.; Passarotto, M.; Leon, A. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. Glia, 2003, 41(2), 161-168
    • (2003) Glia , vol.41 , Issue.2 , pp. 161-168
    • Facchinetti, F.1    Del Giudice, E.2    Furegato, S.3    Passarotto, M.4    Leon, A.5
  • 80
    • 0038678773 scopus 로고    scopus 로고
    • Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor
    • Klegeris, A.; Bissonnette, C.J.; McGeer, P.L. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. B r. J. Pharmacol., 2003, 139(4), 775-786
    • (2003) B R. J. Pharmacol. , vol.139 , Issue.4 , pp. 775-786
    • Klegeris, A.1    Bissonnette, C.J.2    McGeer, P.L.3
  • 81
    • 0037085572 scopus 로고    scopus 로고
    • Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures
    • Molina-Holgado, F.; Molina-Holgado, E.; Guaza, C.; Rothwell, N.J. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. J. Neurosci. Res., 2002, 67(6), 829-836
    • (2002) J. Neurosci. Res. , vol.67 , Issue.6 , pp. 829-836
    • Molina-Holgado, F.1    Molina-Holgado, E.2    Guaza, C.3    Rothwell, N.J.4
  • 82
    • 13244283049 scopus 로고    scopus 로고
    • Synthetic cannabinoid WIN55, 212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes
    • Sheng, W.S.; Hu, S.; Min, X.; Cabral, G.A.; Lokensgard, J.R.; Peterson, P.K. Synthetic cannabinoid WIN55, 212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia, 2005, 49(2), 211-219
    • (2005) Glia , vol.49 , Issue.2 , pp. 211-219
    • Sheng, W.S.1    Hu, S.2    Min, X.3    Cabral, G.A.4    Lokensgard, J.R.5    Peterson, P.K.6
  • 84
    • 0041842648 scopus 로고    scopus 로고
    • Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia
    • Molina-Holgado, F.; Pinteaux, E.; Moore, J.D.; Molina-Holgado, E.; Guaza, C.; Gibson, R.M.; Rothwell, N.J. Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. J. Neurosci., 2003, 23(16), 6470-6474
    • (2003) J. Neurosci. , vol.23 , Issue.16 , pp. 6470-6474
    • Molina-Holgado, F.1    Pinteaux, E.2    Moore, J.D.3    Molina-Holgado, E.4    Guaza, C.5    Gibson, R.M.6    Rothwell, N.J.7
  • 85
    • 0035452419 scopus 로고    scopus 로고
    • Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis
    • Berrendero, F.; Sanchez, A.; Cabranes, A.; Puerta, C.; Ramos, J.A.; Garcia-Merino, A.; Fernandez-Ruiz, J. Changes in cannabinoid CB (1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis. Synapse, 2001, 41(3), 195-202
    • (2001) Synapse , vol.41 , Issue.3 , pp. 195-202
    • Berrendero, F.1    Sanchez, A.2    Cabranes, A.3    Puerta, C.4    Ramos, J.A.5    Garcia-Merino, A.6    Fernandez-Ruiz, J.7
  • 86
    • 59049099828 scopus 로고    scopus 로고
    • A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by down-regulating adhesion molecules
    • Mestre, L.; Docagne, F.; Correa, F.; Loria, F.; Hernangomez, M.; Borrell, J.; Guaza, C. A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by down-regulating adhesion molecules. Mol. Cell. Neurosci., 2009, 40(2), 258-266
    • (2009) Mol. Cell. Neurosci. , vol.40 , Issue.2 , pp. 258-266
    • Mestre, L.1    Docagne, F.2    Correa, F.3    Loria, F.4    Hernangomez, M.5    Borrell, J.6    Guaza, C.7
  • 87
    • 34347397535 scopus 로고    scopus 로고
    • The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration
    • Ashton, J.C.; Glass, M. The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Curr. Neuropharmacol., 2007, 5(2), 73-80
    • (2007) Curr. Neuropharmacol. , vol.5 , Issue.2 , pp. 73-80
    • Ashton, J.C.1    Glass, M.2
  • 89
    • 58049170379 scopus 로고    scopus 로고
    • Endocannabinoid signalling in microglial cells
    • Stella, N. Endocannabinoid signalling in microglial cells. Neuropharmacology, 2009, 56, 244-253
    • (2009) Neuropharmacology , vol.56 , pp. 244-253
    • Stella, N.1
  • 92
    • 0030740514 scopus 로고    scopus 로고
    • The perceived effects of smoked cannabis on patients with multiple sclerosis
    • Consroe, P.; Musty, R.; Rein, J.; Tillery, W.; Pertwee, R. The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur. Neurol., 1997, 38(1), 44-48
    • (1997) Eur. Neurol. , vol.38 , Issue.1 , pp. 44-48
    • Consroe, P.1    Musty, R.2    Rein, J.3    Tillery, W.4    Pertwee, R.5
  • 93
    • 0036669791 scopus 로고    scopus 로고
    • Cannabinoids and multiple sclerosis
    • Pertwee, R.G. Cannabinoids and multiple sclerosis. Pharmacol. Ther., 2002, 95(2), 165-174
    • (2002) Pharmacol. Ther. , vol.95 , Issue.2 , pp. 165-174
    • Pertwee, R.G.1
  • 94
    • 0242654882 scopus 로고    scopus 로고
    • UK MS Research Group. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): Multicentre randomised placebo-controlled trial
    • Zajicek, J.; Fox, P.; Sanders, H.; Wright, D.; Vickery, J.; Nunn, A.; Thompson, A.; UK MS Research Group. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet, 2003, 362(9395), 1517-1526
    • (2003) Lancet , vol.362 , Issue.9395 , pp. 1517-1526
    • Zajicek, J.1    Fox, P.2    Sanders, H.3    Wright, D.4    Vickery, J.5    Nunn, A.6    Thompson, A.7
  • 96
    • 0024596492 scopus 로고
    • Delta 9-tetrahydrocannabinol: A novel treatment for experimental autoimmune encephalomyelitis
    • Lyman, W.D.; Sonett, J.R.; Brosnan, C.F.; Elkin, R.; Bornstein, M.B. Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J. Neuroimmunol., 1989, 23(1), 73-81
    • (1989) J. Neuroimmunol. , vol.23 , Issue.1 , pp. 73-81
    • Lyman, W.D.1    Sonett, J.R.2    Brosnan, C.F.3    Elkin, R.4    Bornstein, M.B.5
  • 101
    • 3943102116 scopus 로고    scopus 로고
    • Unraveling the mechanisms involved in motor neuron degeneration in ALS
    • Bruijn, L.I.; Miller, T.M.; Cleveland, D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci., 2004, 27, 723-749
    • (2004) Annu. Rev. Neurosci. , vol.27 , pp. 723-749
    • Bruijn, L.I.1    Miller, T.M.2    Cleveland, D.W.3
  • 102
    • 16344364681 scopus 로고    scopus 로고
    • Advances in clinical trials for amyotrophic lateral sclerosis
    • Gordon, P.H. Advances in clinical trials for amyotrophic lateral sclerosis. Curr. Neurol. Neurosci. Rep., 2005, 5, 48-54
    • (2005) Curr. Neurol. Neurosci. Rep. , vol.5 , pp. 48-54
    • Gordon, P.H.1
  • 103
    • 0037393176 scopus 로고    scopus 로고
    • An outcome study of riluzole in amyotrophic lateral sclerosis - A population-based study in Ireland, 1996-2000
    • Traynor, B.J.; Alexander, M.; Corr, B.; Frost, E.; Hardiman, O. An outcome study of riluzole in amyotrophic lateral sclerosis-a population-based study in Ireland, 1996-2000. J. Neurol., 2003, 250, 473-479
    • (2003) J. Neurol. , vol.250 , pp. 473-479
    • Traynor, B.J.1    Alexander, M.2    Corr, B.3    Frost, E.4    Hardiman, O.5
  • 104
    • 0036787810 scopus 로고    scopus 로고
    • Inflammatory processes in amyotrophic lateral sclerosis
    • McGeer, P.L.; McGeer, E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve, 2002, 26, 459-470
    • (2002) Muscle Nerve , vol.26 , pp. 459-470
    • McGeer, P.L.1    McGeer, E.G.2
  • 105
    • 17844395669 scopus 로고    scopus 로고
    • Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis
    • Weydt, P.; Moller, T. Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis. Neuroreport, 2005, 16, 527-531
    • (2005) Neuroreport , vol.16 , pp. 527-531
    • Weydt, P.1    Moller, T.2
  • 106
    • 0036953725 scopus 로고    scopus 로고
    • Microglia in diseases of the central nervous system
    • Nelson, P.T.; Soma, L.A.; Lavi, E. Microglia in diseases of the central nervous system. Ann. Med., 2002, 34, 491-500
    • (2002) Ann. Med. , vol.34 , pp. 491-500
    • Nelson, P.T.1    Soma, L.A.2    Lavi, E.3
  • 107
    • 0029792449 scopus 로고    scopus 로고
    • Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: Pathological and immunocytochemical changes
    • Ince, P.G.; Shaw, P.J.; Slade, J.Y.; Jones, C.; Hudgson, P. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol. (Berl), 1996, 92, 395-403
    • (1996) Acta Neuropathol. (Berl) , vol.92 , pp. 395-403
    • Ince, P.G.1    Shaw, P.J.2    Slade, J.Y.3    Jones, C.4    Hudgson, P.5
  • 108
    • 1842471942 scopus 로고    scopus 로고
    • Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study
    • Turner, M.R.; Cagnin, A.; Turkheimer, F.E.; Miller, C.C.; Shaw, C.E.; Brooks, D.J.; Leigh, P.N.; Banati, R.B. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis., 2004, 15, 601-609
    • (2004) Neurobiol. Dis. , vol.15 , pp. 601-609
    • Turner, M.R.1    Cagnin, A.2    Turkheimer, F.E.3    Miller, C.C.4    Shaw, C.E.5    Brooks, D.J.6    Leigh, P.N.7    Banati, R.B.8
  • 109
    • 33645224970 scopus 로고    scopus 로고
    • COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
    • Yiangou, Y.; Facer, P.; Durrenberger, P.; Chessell, I.P.; Naylor, A.; Bountra, C.; Banati, R.R.; Anand, P. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol., 2006, 6, 12
    • (2006) BMC Neurol. , vol.6 , pp. 12
    • Yiangou, Y.1    Facer, P.2    Durrenberger, P.3    Chessell, I.P.4    Naylor, A.5    Bountra, C.6    Banati, R.R.7    Anand, P.8
  • 110
    • 0030927253 scopus 로고    scopus 로고
    • Transgenic animal models of familial amyotrophic lateral sclerosis
    • Gurney, M.E. Transgenic animal models of familial amyotrophic lateral sclerosis. J. Neurol., 1997, 244(Suppl 2), 15-20
    • (1997) J. Neurol. , vol.244 , Issue.SUPPL. 2 , pp. 15-20
    • Gurney, M.E.1
  • 111
    • 33845683331 scopus 로고    scopus 로고
    • Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice
    • Bilsland, L.G.; Dick, J.R.; Pryce, G.; Petrosino, S.; Di Marzo, V.; Baker, D.; Greensmith, L. Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. F A S E B J., 2006, 20, 1003-1005
    • (2006) F A S e B J. , vol.20 , pp. 1003-1005
    • Bilsland, L.G.1    Dick, J.R.2    Pryce, G.3    Petrosino, S.4    Di Marzo, V.5    Baker, D.6    Greensmith, L.7
  • 115
    • 0037043658 scopus 로고    scopus 로고
    • Inflammatory bowel disease
    • Podolsky, D.K. Inflammatory bowel disease. N. Engl. J. Med., 2002, 347(6), 417-429
    • (2002) N. Engl. J. Med. , vol.347 , Issue.6 , pp. 417-429
    • Podolsky, D.K.1
  • 116
    • 23244457833 scopus 로고    scopus 로고
    • Differential expression of cannabinoid receptors in the human colon: Cannabinoids promote epithelial wound healing
    • Wright, K.; Rooney, N.; Feeney, M.; Tate, J.; Robertson, D.; Welham, M.; Ward, S. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology, 2005, 129(2), 437-453
    • (2005) Gastroenterology , vol.129 , Issue.2 , pp. 437-453
    • Wright, K.1    Rooney, N.2    Feeney, M.3    Tate, J.4    Robertson, D.5    Welham, M.6    Ward, S.7
  • 117
    • 0037219120 scopus 로고    scopus 로고
    • Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids
    • Ihenetu, K.; Molleman, A.; Parsons, M.E.; Whelan, C.J. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids. Eur. J. Pharmacol., 2003, 458(1-2), 207-215
    • (2003) Eur. J. Pharmacol. , vol.458 , Issue.1-2 , pp. 207-215
    • Ihenetu, K.1    Molleman, A.2    Parsons, M.E.3    Whelan, C.J.4
  • 118
    • 23344449020 scopus 로고    scopus 로고
    • Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota
    • Elson, C.O.; Cong, Y.; McCracken, V.J.; Dimmitt, R.A.; Lorenz, R.G.; Weaver, C.T. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol. Rev., 2005, 206, 260-276
    • (2005) Immunol. Rev. , vol.206 , pp. 260-276
    • Elson, C.O.1    Cong, Y.2    McCracken, V.J.3    Dimmitt, R.A.4    Lorenz, R.G.5    Weaver, C.T.6
  • 120
    • 33745783119 scopus 로고    scopus 로고
    • Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium
    • Kimball, E.S.; Schneider, C.R.; Wallace, N.H.; Hornby, P.J. Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium. Am. J. Physiol. Gastrointest. Liver Physiol., 2006, 291(2), G364-G371
    • (2006) Am. J. Physiol. Gastrointest. Liver Physiol. , vol.291 , Issue.2
    • Kimball, E.S.1    Schneider, C.R.2    Wallace, N.H.3    Hornby, P.J.4
  • 122
  • 123
    • 38349106773 scopus 로고    scopus 로고
    • AM1241, a CB2-specific agonist protects against immune but not acute colitis
    • Ziring, D.A.; Braun, J. AM1241, a CB2-specific agonist protects against immune but not acute colitis. Gastroenterology, 2007, 132(Suppl 2), A232
    • (2007) Gastroenterology , vol.132 , Issue.SUPPL. 2
    • Ziring, D.A.1    Braun, J.2
  • 124
    • 17644412023 scopus 로고    scopus 로고
    • Inflammation, atherosclerosis, and coronary artery disease
    • Hansson, G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med., 2005, 352(16), 1685-1695
    • (2005) N. Engl. J. Med. , vol.352 , Issue.16 , pp. 1685-1695
    • Hansson, G.K.1
  • 125
    • 0034648768 scopus 로고    scopus 로고
    • Atherosclerosis
    • Lusis, A.J. Atherosclerosis. Nature, 2000, 407, 233-241
    • (2000) Nature , vol.407 , pp. 233-241
    • Lusis, A.J.1
  • 127
    • 0034662868 scopus 로고    scopus 로고
    • The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
    • Malfait, A.M.; Gallily, R.; Sumariwalla, P.F.; Malik, A.S.; Andreakos, E.; Mechoulam, R.; Feldmann, M. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA, 2000, 97(17), 9561-9566
    • (2000) Proc. Natl. Acad. Sci. USA , vol.97 , Issue.17 , pp. 9561-9566
    • Malfait, A.M.1    Gallily, R.2    Sumariwalla, P.F.3    Malik, A.S.4    Andreakos, E.5    Mechoulam, R.6    Feldmann, M.7
  • 128
    • 33751100172 scopus 로고    scopus 로고
    • R-(+)-[2, 3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1, 2, 3-de]-1, 4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: Partial involvement of the CB(2) receptor
    • Sanchez, A.J.; Gonzalez-Perez, P.; Galve-Roperh, I.; Garcia-Merino, A. R-(+)-[2, 3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1, 2, 3-de]-1, 4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor. Biochem. Pharmacol., 2006, 72(12), 1697-1706
    • (2006) Biochem. Pharmacol. , vol.72 , Issue.12 , pp. 1697-1706
    • Sanchez, A.J.1    Gonzalez-Perez, P.2    Galve-Roperh, I.3    Garcia-Merino, A.4
  • 129
    • 17144462251 scopus 로고    scopus 로고
    • Therapeutic action of cannabinoids in a murine model of multiple sclerosis
    • Arevalo-Martin, A.; Vela, J.M.; Molina-Holgado, E.; Borrell, J.; Guaza, C. Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J. Neurosci., 2003, 23(7), 2511-2516
    • (2003) J. Neurosci. , vol.23 , Issue.7 , pp. 2511-2516
    • Arevalo-Martin, A.1    Vela, J.M.2    Molina-Holgado, E.3    Borrell, J.4    Guaza, C.5
  • 132
    • 12344253624 scopus 로고    scopus 로고
    • Rheumatoid arthritis, inflammation, and atherosclerosis
    • Hurlimann, D.; Enseleit, F.; Ruschitzka, F. Rheumatoid arthritis, inflammation, and atherosclerosis. Herz, 2004, 29, 760-768
    • (2004) Herz , vol.29 , pp. 760-768
    • Hurlimann, D.1    Enseleit, F.2    Ruschitzka, F.3
  • 134
    • 23044486763 scopus 로고    scopus 로고
    • Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
    • Croxford, J.L.; Yamamura, T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? J. Neuroimmunol., 2005, 166, 3-18
    • (2005) J. Neuroimmunol. , vol.166 , pp. 3-18
    • Croxford, J.L.1    Yamamura, T.2
  • 136
    • 41849090731 scopus 로고    scopus 로고
    • Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid
    • Parker, J.; Atez, F.; Rossetti, R.G.; Skulas, A.; Patel, R.; Zurier, R.B. Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid. Rheumatol Int., 2008, 28, 631-635
    • (2008) Rheumatol Int. , vol.28 , pp. 631-635
    • Parker, J.1    Atez, F.2    Rossetti, R.G.3    Skulas, A.4    Patel, R.5    Zurier, R.B.6
  • 137
    • 0037441413 scopus 로고    scopus 로고
    • Suppression of human monocyte interleukin-1 ßproduction by ajulemic acid, a nonpsycho active cannabinoid
    • Zurier, R.B.; Rossetti, R.G.; Burstein, S.H.; Bidinger, B. Suppression of human monocyte interleukin-1 ßproduction by ajulemic acid, a nonpsycho active cannabinoid. Biochem. Pharmacol, 2003, 65, 649-655
    • (2003) Biochem. Pharmacol , vol.65 , pp. 649-655
    • Zurier, R.B.1    Rossetti, R.G.2    Burstein, S.H.3    Bidinger, B.4
  • 138
    • 38449111261 scopus 로고    scopus 로고
    • Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells
    • George, K.L.; Saltman, L.H.; Stein, G.S.; Lian, J.B.; Zurier, R.B. Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells. J. Cell. Physiol, 2008, 214, 714-720
    • (2008) J. Cell. Physiol , vol.214 , pp. 714-720
    • George, K.L.1    Saltman, L.H.2    Stein, G.S.3    Lian, J.B.4    Zurier, R.B.5
  • 139
    • 0035901090 scopus 로고    scopus 로고
    • Inflammation and cancer: Back to Virchow?
    • Balkwill, F.; Mantovani, A. Inflammation and cancer: back to Virchow? Lancet, 2001, 357, 539-545
    • (2001) Lancet , vol.357 , pp. 539-545
    • Balkwill, F.1    Mantovani, A.2
  • 140
    • 0032881237 scopus 로고    scopus 로고
    • Therapeutic approaches for ischemia/reperfusion injury in the liver
    • Fan, C.; Zwacka, R.M.; Engelhardt, J.F Therapeutic approaches for ischemia/reperfusion injury in the liver. J. Mol Med., 1999, 77, 577-592
    • (1999) J. Mol Med. , vol.77 , pp. 577-592
    • Fan, C.1    Zwacka, R.M.2    Engelhardt, J.F.3
  • 141
    • 0141594593 scopus 로고    scopus 로고
    • Apoptosis versus oncotic necrosis in hepatic ischemia/rep erfusion injury
    • Jaeschke, H.; Lemasters, J.J. Apoptosis versus oncotic necrosis in hepatic ischemia/rep erfusion injury. Gastroenterology, 2003, 125, 1246-1257
    • (2003) Gastroenterology , vol.125 , pp. 1246-1257
    • Jaeschke, H.1    Lemasters, J.J.2
  • 142
    • 20344379953 scopus 로고    scopus 로고
    • Ischemia and reperfusion injury in liver transplantation
    • Kupiec-Weglinski, J.W.; Busuttil, R.W. Ischemia and reperfusion injury in liver transplantation. Transpl. Proc, 2005, 37, 1653-1656
    • (2005) Transpl. Proc , vol.37 , pp. 1653-1656
    • Kupiec-Weglinski, J.W.1    Busuttil, R.W.2
  • 143
    • 18144401711 scopus 로고    scopus 로고
    • Anti-inflammatory approaches to the prevention of ischemia/rep erfusion injury in solid organ transplantation
    • Husted, T.L.; Lentsch, A.B. Anti-inflammatory approaches to the prevention of ischemia/rep erfusion injury in solid organ transplantation. Curr. Opin. Investig. Drugs, 2005, 6, 508-512
    • (2005) Curr. Opin. Investig. Drugs , vol.6 , pp. 508-512
    • Husted, T.L.1    Lentsch, A.B.2
  • 144
    • 21644433002 scopus 로고    scopus 로고
    • Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury
    • Szabo, G.; Bahrle, S. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury. Curr. Vasc. Pharmacol, 2005, 3, 215-220
    • (2005) Curr. Vasc. Pharmacol , vol.3 , pp. 215-220
    • Szabo, G.1    Bahrle, S.2
  • 145
    • 33644631485 scopus 로고    scopus 로고
    • Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol
    • Pacher, P.; Nivorozhkin, A.; Szabo, C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol. Rev., 2006, 58, 87-114
    • (2006) Pharmacol. Rev. , vol.58 , pp. 87-114
    • Pacher, P.1    Nivorozhkin, A.2    Szabo, C.3
  • 146
    • 33748703859 scopus 로고    scopus 로고
    • The endocannabinoid system as an emerging target of pharmacotherapy
    • Pacher, P.; Bátkai, S.; Kunos, G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev., 2006, 58, 389-462
    • (2006) Pharmacol. Rev. , vol.58 , pp. 389-462
    • Pacher, P.1    Bátkai, S.2    Kunos, G.3
  • 148
    • 19444369394 scopus 로고    scopus 로고
    • Blood pressure regulation by endocannabinoids and their receptors
    • Pacher, P.; Bátkai, S.; Kunos, G. Blood pressure regulation by endocannabinoids and their receptors. Neuropharmacology, 2005, 48, 1130-1138
    • (2005) Neuropharmacology , vol.48 , pp. 1130-1138
    • Pacher, P.1    Bátkai, S.2    Kunos, G.3
  • 152
    • 78249232046 scopus 로고    scopus 로고
    • Review on clinical studies with cannabis and cannabinoids 2005-2009
    • special issue
    • Hazekamp, A.; Grotenhermen, F. Review on clinical studies with cannabis and cannabinoids 2005-2009. Cannabinoids, 2010, 5(special issue), 1-21
    • (2010) Cannabinoids , vol.5 , pp. 1-21
    • Hazekamp, A.1    Grotenhermen, F.2
  • 154
    • 84880856297 scopus 로고    scopus 로고
    • PBRHome Accessed Apr 19, 2012
    • PBRHome. Glenmark completes Phase I inflammatory pain trial. http://drugdiscovery.pharmaceutical-business-review.com/news/ glenmark-completes-phase-i-inflammatory-pain-trial-14 0409 (Accessed Apr 19, 2012)
    • Glenmark Completes Phase i Inflammatory Pain Trial
  • 158
  • 159
    • 0033381793 scopus 로고    scopus 로고
    • 3-(1', 1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: Synthesis of selective ligands for the CB2 receptor
    • Huffman, J.W.; Liddle, J.; Yu, S.; Aung, M.; Abood, M.E.; Wiley, J.L.; Martin, B.R. 3-(1', 1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg. Med. Chem., 1999, 7(12), 2905-2914
    • (1999) Bioorg. Med. Chem. , vol.7 , Issue.12 , pp. 2905-2914
    • Huffman, J.W.1    Liddle, J.2    Yu, S.3    Aung, M.4    Abood, M.E.5    Wiley, J.L.6    Martin, B.R.7
  • 160
    • 28944438774 scopus 로고    scopus 로고
    • The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro
    • Jonsson, K.O.; Persson, E.; Fowler, C.J. The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro. Life Sci., 2006, 78(6), 598-606
    • (2006) Life Sci. , vol.78 , Issue.6 , pp. 598-606
    • Jonsson, K.O.1    Persson, E.2    Fowler, C.J.3
  • 161
    • 0346993609 scopus 로고    scopus 로고
    • A novel methodology for the synthesis of 1-desoxy-Delta(8)-
    • Sun, H.; Mahadevan, A.; Razdan, R.K. A novel methodology for the synthesis of 1-desoxy-Delta(8)-tetrahydrocannabinol (THC) analogues. Tet. Lett, 2004, 45, 615-617
    • (2004) Tet. Lett , vol.45 , pp. 615-617
    • Sun, H.1    Mahadevan, A.2    Razdan, R.K.3
  • 162
    • 78650807828 scopus 로고    scopus 로고
    • The CB(2) cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects
    • Kinsey, S.G.; Mahadevan, A.; Zhao, B.; Sun, H.; Naidu, P.S.; Razdan, R.K.; Selley, D.E.; Imad Damaj, M.; Lichtman, A.H. The CB(2) cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects. Neuropharmacology, 2011, 60(2-3), 244-251
    • (2011) Neuropharmacology , vol.60 , Issue.2-3 , pp. 244-251
    • Kinsey, S.G.1    Mahadevan, A.2    Zhao, B.3    Sun, H.4    Naidu, P.S.5    Razdan, R.K.6    Selley, D.E.7    Imad Damaj, M.8    Lichtman, A.H.9
  • 166
    • 37249091964 scopus 로고    scopus 로고
    • Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis
    • Rajesh, M.; Pan, H.; Mukhopadhyay, P.; Bátkai, S.; Osei-Hyiaman, D.; Haskó, G.; Liaudet, L.; Gao, B.; Pacher, P. Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J. Leukoc. Biol., 2007, 82, 1382-1389
    • (2007) J. Leukoc. Biol. , vol.82 , pp. 1382-1389
    • Rajesh, M.1    Pan, H.2    Mukhopadhyay, P.3    Bátkai, S.4    Osei-Hyiaman, D.5    Haskó, G.6    Liaudet, L.7    Gao, B.8    Pacher, P.9
  • 167
    • 21644464904 scopus 로고    scopus 로고
    • CB2 receptor ligands
    • Huffman, J.W. CB2 receptor ligands. Mini Rev. Med. Chem., 2005, 5(7), 641-649
    • (2005) Mini Rev. Med. Chem. , vol.5 , Issue.7 , pp. 641-649
    • Huffman, J.W.1
  • 169
    • 34548538407 scopus 로고    scopus 로고
    • Cannabinoids and the Endocannabinoid System
    • Grotenhermen, F. Cannabinoids and the Endocannabinoid System. Cannabinoids, 2006, 1(1), 10-14
    • (2006) Cannabinoids , vol.1 , Issue.1 , pp. 10-14
    • Grotenhermen, F.1
  • 170
    • 78651277573 scopus 로고    scopus 로고
    • Acute effects of a novel peripheral selective cannabinoid-2-receptor agonist (cannabinor) on bladder function in conscious rats
    • Gratzke, C.; Streng, T.; Stief, C.G.; Downs, T.R.; Alroy, I.; Rosenbaum, J.S.; Hedlund, P. Acute effects of a novel peripheral selective cannabinoid-2-receptor agonist (cannabinor) on bladder function in conscious rats. Eur. Urol. Suppl., 2010, 8, 271
    • (2010) Eur. Urol. Suppl. , vol.8 , pp. 271
    • Gratzke, C.1    Streng, T.2    Stief, C.G.3    Downs, T.R.4    Alroy, I.5    Rosenbaum, J.S.6    Hedlund, P.7
  • 171
    • 33845196807 scopus 로고    scopus 로고
    • Pharmos Accessed Oct 27, 2011
    • Pharmos. CB2-selective program: cannabinor. http://www.pharmoscorp.com/ development/cannabinor.html (Accessed Oct 27, 2011)
    • CB2-selective Program: Cannabinor
  • 174
    • 0030425575 scopus 로고    scopus 로고
    • Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands
    • Showalter, V.M.; Compton, D.R.; Martin, B.R.; Abood, M.E. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther., 1996, 278(3), 989-999
    • (1996) J. Pharmacol. Exp. Ther. , vol.278 , Issue.3 , pp. 989-999
    • Showalter, V.M.1    Compton, D.R.2    Martin, B.R.3    Abood, M.E.4
  • 178
    • 0026969158 scopus 로고
    • Aminoalkylindole analogs: Cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol
    • Compton, D.R.; Gold, L.H.; Ward, S.J.; Balster, R.L.; Martin, B.R. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther., 1992, 263(3), 1118-1126
    • (1992) J. Pharmacol. Exp. Ther. , vol.263 , Issue.3 , pp. 1118-1126
    • Compton, D.R.1    Gold, L.H.2    Ward, S.J.3    Balster, R.L.4    Martin, B.R.5
  • 179
    • 0035800564 scopus 로고    scopus 로고
    • Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands
    • Smith, S.R.; Terminelli, C.; Denhardt, G. Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands. Eur. J. Pharmacol., 2001, 425(1), 73-83
    • (2001) Eur. J. Pharmacol. , vol.425 , Issue.1 , pp. 73-83
    • Smith, S.R.1    Terminelli, C.2    Denhardt, G.3
  • 180
    • 0034069673 scopus 로고    scopus 로고
    • Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice
    • Smith, S.R.; Terminelli, C.; Denhardt, G. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. J. Pharmacol. Exp. Ther., 2000, 293(1), 136-150
    • (2000) J. Pharmacol. Exp. Ther. , vol.293 , Issue.1 , pp. 136-150
    • Smith, S.R.1    Terminelli, C.2    Denhardt, G.3
  • 181
    • 0036179292 scopus 로고    scopus 로고
    • Effect of the cannabinoid receptor ligand, WIN 55, 212-2, on superoxide anion and TNF-alpha production by human mononuclear cells
    • Germain, N.; Boichot, E.; Advenier, C.; Berdyshev, E.V.; Lagente, V. Effect of the cannabinoid receptor ligand, WIN 55, 212-2, on superoxide anion and TNF-alpha production by human mononuclear cells. Int. Immunopharmacol., 2002, 2(4), 537-543
    • (2002) Int. Immunopharmacol. , vol.2 , Issue.4 , pp. 537-543
    • Germain, N.1    Boichot, E.2    Advenier, C.3    Berdyshev, E.V.4    Lagente, V.5
  • 182
    • 33846335526 scopus 로고    scopus 로고
    • Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation
    • Marchalant, Y.; Rosi, S.; Wenk, G.L. Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation. Neuroscience, 2007, 144(4), 1516-1522
    • (2007) Neuroscience , vol.144 , Issue.4 , pp. 1516-1522
    • Marchalant, Y.1    Rosi, S.2    Wenk, G.L.3
  • 183
    • 33646508077 scopus 로고    scopus 로고
    • Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol
    • Oka, S.; Wakui, J.; Gokoh, M.; Kishimoto, S.; Sugiura, T. Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2- arachidonoylglycerol. Eur. J. Pharm., 2006, 538, 154-162
    • (2006) Eur. J. Pharm. , vol.538 , pp. 154-162
    • Oka, S.1    Wakui, J.2    Gokoh, M.3    Kishimoto, S.4    Sugiura, T.5
  • 185
    • 0027225185 scopus 로고
    • Characterization of a region of steric interference at the cannabinoid receptor using the active analog approach
    • Reggio, P.H.; Panu, A.M.; Miles, S. Characterization of a region of steric interference at the cannabinoid receptor using the active analog approach. J. Med Chem., 1993, 36(12), 1761-1771
    • (1993) J. Med Chem. , vol.36 , Issue.12 , pp. 1761-1771
    • Reggio, P.H.1    Panu, A.M.2    Miles, S.3
  • 186
    • 0028323255 scopus 로고
    • Design, Synthesis and Pharmacology of Cannabimimetic Indoles
    • Huffman, J.W.; Dong, D. Design, Synthesis and Pharmacology of Cannabimimetic Indoles. Bioorg. Med. Chem. Lett., 1994, 4(4), 563-566
    • (1994) Bioorg. Med. Chem. Lett. , vol.4 , Issue.4 , pp. 563-566
    • Huffman, J.W.1    Dong, D.2
  • 187
    • 0026969158 scopus 로고
    • Aminoalkylindole analogs: Cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol
    • Compton, D.R.; Gold, L.H.; Ward, S.J.; Balster, R.L.; Martin, B.R. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther., 1992, 263(3), 1118-1126
    • (1992) J. Pharmacol. Exp. Ther. , vol.263 , Issue.3 , pp. 1118-1126
    • Compton, D.R.1    Gold, L.H.2    Ward, S.J.3    Balster, R.L.4    Martin, B.R.5
  • 188
    • 0029081885 scopus 로고
    • Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens
    • Pertwee, R.G.; Griffin, G.; Lainton, J.A.H.; Huffman, J.W. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. Eur. J. Pharmacol., 1995, 284, 241-247
    • (1995) Eur. J. Pharmacol. , vol.284 , pp. 241-247
    • Pertwee, R.G.1    Griffin, G.2    Lainton, J.A.H.3    Huffman, J.W.4
  • 192
    • 0033661798 scopus 로고    scopus 로고
    • Cannabinoid receptors and the regulation of immune response
    • Berdyshev, E.V. Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids, 2000, 108, 169-190
    • (2000) Chem. Phys. Lipids , vol.108 , pp. 169-190
    • Berdyshev, E.V.1
  • 193
    • 14244264502 scopus 로고    scopus 로고
    • Prevention of Alzheimer's disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation
    • Ramirez, B.G.; Blazquez, C.; Gomez del Pulgar, T.; Guzman, M.; de Ceballos, M.L. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J. Neurosci., 2005, 25(8), 1904-1913
    • (2005) J. Neurosci. , vol.25 , Issue.8 , pp. 1904-1913
    • Ramirez, B.G.1    Blazquez, C.2    Gomez Del Pulgar, T.3    Guzman, M.4    De Ceballos, M.L.5
  • 194
    • 33744827120 scopus 로고    scopus 로고
    • Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes
    • Ghosh, S.; Preet, A.; Groopman, J.E.; Ganju, R.K. Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes. Mol. Immunol., 2006, 43(14), 2169-2179
    • (2006) Mol. Immunol. , vol.43 , Issue.14 , pp. 2169-2179
    • Ghosh, S.1    Preet, A.2    Groopman, J.E.3    Ganju, R.K.4
  • 195
    • 41549162387 scopus 로고    scopus 로고
    • CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signalling pathways
    • Montecucco, F.; Burger, F.; Mach, F.; Steffens, S. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signalling pathways. Am. J. Physiol. Heart Circ. Physiol., 2008, 294(3), H1145-1155
    • (2008) Am. J. Physiol. Heart Circ. Physiol. , vol.294 , Issue.3
    • Montecucco, F.1    Burger, F.2    MacH, F.3    Steffens, S.4
  • 202
    • 38349119715 scopus 로고    scopus 로고
    • Cannabinoid CB2 receptors: A therapeutic target for the treatment of inflammatory and neuropathic pain
    • Guindon, J.; Hohmann, A.G. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. B r. J. Pharmacol., 2008, 153(2), 319-334.
    • (2008) B R. J. Pharmacol. , vol.153 , Issue.2 , pp. 319-334
    • Guindon, J.1    Hohmann, A.G.2
  • 204
    • 33746261289 scopus 로고    scopus 로고
    • AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis
    • Kim, K.; Moore, D.H.; Makriyannis, A.; Abood, M.E. AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis. Eur. J. Pharmacol., 2006, 542(1-3), 100-105
    • (2006) Eur. J. Pharmacol. , vol.542 , Issue.1-3 , pp. 100-105
    • Kim, K.1    Moore, D.H.2    Makriyannis, A.3    Abood, M.E.4
  • 205
    • 33947278309 scopus 로고    scopus 로고
    • The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
    • Shoemaker, J.L.; Seely, K.A.; Reed, R.L.; Crow, J.P.; Prather, P.L. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J. Neurochem., 2007, 101(1), 87-98
    • (2007) J. Neurochem. , vol.101 , Issue.1 , pp. 87-98
    • Shoemaker, J.L.1    Seely, K.A.2    Reed, R.L.3    Crow, J.P.4    Prather, P.L.5
  • 206
    • 70349128141 scopus 로고    scopus 로고
    • Cannabinoid-1 receptor inverse agonists: Current understanding of mechanism of action and unanswered questions
    • Fong, T.M.; Heymsfield, S.B. Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions. Int. J. Obes. (Lond.), 2009, 33(9), 947-955
    • (2009) Int. J. Obes. (Lond.) , vol.33 , Issue.9 , pp. 947-955
    • Fong, T.M.1    Heymsfield, S.B.2
  • 207
    • 1842832439 scopus 로고    scopus 로고
    • Tricyclic pyrazoles. Part 1. Synthesis and biological evaluation of novel 1, 4-dihydroindeno[1, 2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors
    • Mussinu, J.M.; Ruiu, S.; Mulé, A.C.; Pau, A.; Carai, M.A.M.; Loriga, G.; Murineddu, G.; Pinna, G.A. Tricyclic pyrazoles. Part 1. Synthesis and biological evaluation of novel 1, 4-dihydroindeno[1, 2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors. Bioorg. Med. Chem., 2003, 11, 251-263
    • (2003) Bioorg. Med. Chem. , vol.11 , pp. 251-263
    • Mussinu, J.M.1    Ruiu, S.2    Mulé, A.C.3    Pau, A.4    Carai, M.A.M.5    Loriga, G.6    Murineddu, G.7    Pinna, G.A.8
  • 208
    • 16244420759 scopus 로고    scopus 로고
    • Tricyclic pyrazoles. Part 2. Synthesis and biological evaluation of novel 4, 5-dihydro-1H-benzo[g]indazole-based ligands for cannabinoid receptors
    • Murineddu, G.; Ruiu, S.; Mussinu, J.M.; Loriga, G.; Grella, G.E.; Carai, M.A.M.; Lazzari, P.; Pani, L.; Pinna, G.A. Tricyclic pyrazoles. Part 2. Synthesis and biological evaluation of novel 4, 5-dihydro-1H-benzo[g]indazole- based ligands for cannabinoid receptors. Bioorg. Med. Chem., 2005, 13, 3309-3320
    • (2005) Bioorg. Med. Chem. , vol.13 , pp. 3309-3320
    • Murineddu, G.1    Ruiu, S.2    Mussinu, J.M.3    Loriga, G.4    Grella, G.E.5    Carai, M.A.M.6    Lazzari, P.7    Pani, L.8    Pinna, G.A.9
  • 210
    • 28544446066 scopus 로고    scopus 로고
    • Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2', 4'-dichlorophenyl)-N-piperidin-1-yl-1, 4, 5, 6-tetrahydrobenzo[6, 7]cyclohepta[1, 2-c]pyrazole-3-carboxamide
    • Murineddu, G.; Ruiu, S.; Loriga, G.; Manca, I.; Lazzari, P.; Reali, R.; Pani, L.; Toma, L.; Pinna, G.A. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2', 4'-dichlorophenyl)-N-piperidin-1-yl-1, 4, 5, 6-tetrahydrobenzo[6, 7]cyclohepta[1, 2-c]pyrazole-3-carboxamide. J. Med. Chem., 2005, 48(23), 7351-7362
    • (2005) J. Med. Chem. , vol.48 , Issue.23 , pp. 7351-7362
    • Murineddu, G.1    Ruiu, S.2    Loriga, G.3    Manca, I.4    Lazzari, P.5    Reali, R.6    Pani, L.7    Toma, L.8    Pinna, G.A.9
  • 211
    • 33845496711 scopus 로고    scopus 로고
    • Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2', 4'-dichlorophenyl)-6- methyl-N-piperidin-1-yl-1, 4-dihydroindeno[1, 2-c]pyrazole-3-carboxamide
    • Murineddu, G.; Lazzari, P.; Ruiu, S.; Sanna, A.; Loriga, G.; Manca, I.; Falzoi, M.; Dessì, C.; Curzu, M.M.; Chelucci, G.; Pani, L.; Pinna, G.A. Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2', 4'-dichlorophenyl)-6-methyl- N-piperidin-1-yl-1, 4-dihydroindeno[1, 2-c]pyrazole-3-carboxamide. J. Med. Chem., 2006, 49(25), 7502-7512
    • (2006) J. Med. Chem. , vol.49 , Issue.25 , pp. 7502-7512
    • Murineddu, G.1    Lazzari, P.2    Ruiu, S.3    Sanna, A.4    Loriga, G.5    Manca, I.6    Falzoi, M.7    Dessì, C.8    Curzu, M.M.9    Chelucci, G.10    Pani, L.11    Pinna, G.A.12
  • 215
    • 0034618541 scopus 로고    scopus 로고
    • Privileged molecules for protein binding identified from NMR-based screening
    • Hajduk, P.J.; Bures, M.; Praestgaard, J.; Fesik, S.W. Privileged molecules for protein binding identified from NMR-based screening. J. Med. Chem., 2000, 43(18), 3443-3447
    • (2000) J. Med. Chem. , vol.43 , Issue.18 , pp. 3443-3447
    • Hajduk, P.J.1    Bures, M.2    Praestgaard, J.3    Fesik, S.W.4
  • 216
    • 30444443786 scopus 로고    scopus 로고
    • Novel 4-oxo-1, 4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: Synthesis, pharmacological properties and molecular modeling
    • Stern, E.; Muccioli, G.G.; Millet, R.; Goossens, J.F.; Farce, A.; Chavatte, P.; Poupaert, J.H.; Lambert, D.M.; Depreux, P.; Hénichart, J.P. Novel 4-oxo-1, 4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling. J. Med. Chem., 2006, 49(1), 70-79
    • (2006) J. Med. Chem. , vol.49 , Issue.1 , pp. 70-79
    • Stern, E.1    Muccioli, G.G.2    Millet, R.3    Goossens, J.F.4    Farce, A.5    Chavatte, P.6    Poupaert, J.H.7    Lambert, D.M.8    Depreux, P.9    Hénichart, J.P.10
  • 217
    • 35848957071 scopus 로고    scopus 로고
    • Pharmacomodulations around the 4-Oxo-1, 4-dihydroquinoline-3- carboxamides, a Class of Potent CB2-Selective Cannabinoid Receptor Ligands: Consequences in Receptor Affinity and Functionality
    • Stern, E.; Muccioli, G.G.; Bosier, B.; Hamtiaux, L.; Millet, R.; Poupaert, J.H.; Hénichart, J.P.; Depreux, P.; Goossens, J.-F.; Lambert, D.M. Pharmacomodulations around the 4-Oxo-1, 4-dihydroquinoline-3-carboxamides, a Class of Potent CB2-Selective Cannabinoid Receptor Ligands: Consequences in Receptor Affinity and Functionality. J. Med. Chem., 2007, 50(22), 5471-5484
    • (2007) J. Med. Chem. , vol.50 , Issue.22 , pp. 5471-5484
    • Stern, E.1    Muccioli, G.G.2    Bosier, B.3    Hamtiaux, L.4    Millet, R.5    Poupaert, J.H.6    Hénichart, J.P.7    Depreux, P.8    Goossens, J.-F.9    Lambert, D.M.10
  • 218
    • 78649506916 scopus 로고    scopus 로고
    • 4-Oxo-1, 4-Dihydroquinoline-3-Carboxamides Derivatives As New Potent and Selective Cb2 Agonists with Anti-Inflammatory and Analgesic Properties in the Gut
    • Body-Malapel, M.; El-Bakali, J.; Mérour, E.; Stern, E.; Millet, R.; Desreumaux, P. 4-Oxo-1, 4-Dihydroquinoline-3-Carboxamides Derivatives As New Potent and Selective Cb2 Agonists with Anti-Inflammatory and Analgesic Properties in the Gut. Gastroenterology, 2008, 134(4, Suppl 1), A-107
    • (2008) Gastroenterology , vol.134 , Issue.4 SUPPL. 1
    • Body-Malapel, M.1    El-Bakali, J.2    Mérour, E.3    Stern, E.4    Millet, R.5    Desreumaux, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.